Literature DB >> 10728786

D,L-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, induces differentiation in MEL cells.

S K Choudhary1, D Sharma, A Dixit.   

Abstract

In the present study, the effect of D,L-alpha-difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase (ODC), on Friend's murine erythroleukemia (MEL) cell differentiation is investigated. DFMO was able to induce differentiation of MEL cells in culture as determined by haemoglobin (Hb) content and percentage of cells synthesizing Hb detected by benzidine staining. DFMO at a concentration of 2 mM resulted in about 70% benzidine-positive cells on the fifth day. There was a time-dependent increase in the percentage of benzidine-positive cells starting from day three. However, only a 24 h presence of DFMO in the medium was required to induce differentiation suggesting that DFMO switches on a pathway during this period leading to terminal differentiation of MEL cells. DFMO induced differentiation of MEL cells was sensitive to dexamethasone and 5-bromo-2'-deoxyuridine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10728786     DOI: 10.1006/cbir.1999.0398

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  4 in total

1.  A definitive role of ornithine decarboxylase in photocarcinogenesis.

Authors:  N Ahmad; A C Gilliam; S K Katiyar; T G O'Brien; H Mukhtar
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  Anti-leukemic principle(s) from Momordica charantia seeds induce differentiation of HL-60 cells through ERK/MAPK signalling pathway.

Authors:  Jeetesh Sharma; Punit Prabha; Rohit Sharma; Shalini Gupta; Aparna Dixit
Journal:  Cytotechnology       Date:  2022-09-12       Impact factor: 2.040

3.  Antileukemic Potential of Momordica charantia Seed Extracts on Human Myeloid Leukemic HL60 Cells.

Authors:  Ramani Soundararajan; Punit Prabha; Umesh Rai; Aparna Dixit
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-13       Impact factor: 2.629

4.  Polyamine Biosynthetic Pathway as a Drug Target for Osteosarcoma Therapy.

Authors:  Rebecca R Weicht; Chad R Schultz; Dirk Geerts; Katie L Uhl; André S Bachmann
Journal:  Med Sci (Basel)       Date:  2018-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.